Of the six SLFN genes, Schlafen 5 (SLFN5) has been consistently shown to be induced by type I IFNs in these cancers [18,19,20], as well as in triple-negative breast cancer, as shown by others [18,19,20,21]. This evidence concerns the gene SLFN5 and triple-negative breast carcinoma.